Assured Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-9,582
Closed -$2.27M 142
2019
Q1
$2.27M Sell
9,582
-28,584
-75% -$9M 0.03% 259
2018
Q4
$11.5M Buy
38,166
+13,454
+54% +$4.29M 0.33% 55
2018
Q3
$8.73M Buy
24,712
+1,958
+9% +$674K 0.16% 123
2018
Q2
$6.6M Buy
22,754
+2,537
+13% +$713K 0.12% 176
2018
Q1
$5.54M Buy
20,217
+9,891
+96% +$3.07M 0.13% 202
2017
Q4
$3.29M Buy
10,326
+4,884
+90% +$1.57M 0.07% 296
2017
Q3
$1.7M Buy
5,442
+1,377
+34% +$408K 0.03% 351
2017
Q2
$1.1M Buy
4,065
+1,164
+40% +$308K 0.02% 374
2017
Q1
$793K Sell
2,901
-1,431
-33% -$405K 0.02% 354
2016
Q4
$1.23M Buy
+4,332
New +$1.28M 0.02% 278
2016
Q2
Sell
-2,737
Closed -$712K 589
2016
Q1
$712K Buy
+2,737
New +$723K 0.02% 262
2015
Q4
Sell
-269,820
Closed -$78.7M 639
2015
Q3
$78.7M Buy
269,820
+267,919
+14,094% +$88.5M 1.44% 14
2015
Q2
$768K Buy
1,901
+1,070
+129% +$429K 0.01% 274
2015
Q1
$351K Buy
+831
New +$328K 0.01% 310

Other funds holding BIIB

Assured Investment Management's BIIB Position: Q2 2019 in Review

Assured Investment Management sold out of Biogen (BIIB) in Q2 2019, closing a stake of 9,582 shares — an estimated $2.27M sold.

Assured Investment Management first reported a position in BIIB in Q1 2015 and held it in 14 quarters. The position peaked at $78.7M in Q3 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Assured Investment Management reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 9,582 Biogen shares in Q2 2019, an estimated $2.27M.
  • Assured Investment Management first reported a position in Biogen in Q1 2015 and held it in 14 quarters.
  • Assured Investment Management's Biogen position peaked at $78.7M in Q3 2015.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.